A systematic review proposes a clinically actionable biomarker stratification for immunotherapy in microsatellite-stable ...

Eleven studies using machine learning, single-cell profiling, imaging, liquid biopsy and clinical data identify candidate ...

Alpheus Medical, Inc., a clinical-stage oncology company developing Porphyrin Metabolite Activation (PoMA™) for the treatment of glioblastoma (GBM), today announced that new biomarker data from its ...

NEW YORK, August 25, 2026--(BUSINESS WIRE)--Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the expansion ...

Tissue samples collected from patients with breast cancer during treatment may help explore therapy selection and predict toxicities. Although there are data for fam-trastuzumab deruxtecan-nxki (T-DXd ...

Paul L. Swiecicki, MD, of the University of Michigan Rogel Cancer Center, addresses whether biomarker testing is needed to ...

Oxidative stress biomarkers predicted prostate cancer recurrence risk, while LAMP5 knockdown reduced cancer cell proliferation, migration and invasion.

Please provide your email address to receive an email when new articles are posted on . About a third of patients do not have a biomarker used to track treatment progress in pancreatic cancer. An AI ...

Detailed price information for Briacell Therapeutics Corp (BCTX-Q) from The Globe and Mail including charting and trades.

The retrospective analyses demonstrate that survival with BOT+BAL is associated with the balance of two opposing biological factors: systemic inflammation in the blood (associated with poorer outcomes ...